Raphael Pharmaceutical RAPH
OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Selling, General & Administrative (2020 - 2024)

Raphael Pharmaceutical (RAPH) Selling, General & Administrative (2020 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 317.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -1.80 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 206.70 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 1.13 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 439.70 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 449.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Raphael Pharmaceutical 28.25 Mn 28.25 Mn - 159,000.00

Historic Data

Download Data
DateValue
Dec 31, 2024 183,000.00
Sep 30, 2024 157,000.00
Jun 30, 2024 225,000.00
Mar 31, 2024 168,000.00
Dec 31, 2023 274,000.00
Sep 30, 2023 219,000.00
Jun 30, 2023 126,000.00
Mar 31, 2023 144,000.00
Dec 31, 2022 428,000.00
Sep 30, 2022 1.09 Mn
Jun 30, 2022 528,000.00
Mar 31, 2022 89,000.00
Dec 31, 2021 350,000.00
Sep 30, 2021 257,000.00
Jun 30, 2021 163,000.00
Mar 31, 2021 83,000.00
Dec 31, 2020 7,000.00